Skip to main content

Table 5 Antimicrobial resistance profiles of A. baumannii and P. aeruginosa isolates from participants presumptive for nosocomial infection at FHRH, Bahir Dar, Northwest Ethiopia, April to July, 2018

From: Multi-drug resistance of blood stream, urinary tract and surgical site nosocomial infections of Acinetobacter baumannii and Pseudomonas aeruginosa among patients hospitalized at Felegehiwot referral hospital, Northwest Ethiopia: a cross-sectional study

AntimicrobialsA.baumanniiP.aeruginosaTotal
# TR %# TR %# TR%
Ampicillin99 (100)1111 (100)2020 (100)
Amoxicillin-clavulanic acid98 (88.9)1111 (100)2019 (95)
Piperacillin99 (100)1111 (100)2020 (100)
Cefotaxime98 (88.9)1111 (100)2019 (95)
Ceftriaxone98 (88.9)1111 (100)2019 (95)
Ceftazidime97 (77.8)117 (63.6)2014 (70)
Ciprofloxacin94 (44.5)114 (36.4)208 (40)
Gentamicin98 (88.9)116 (54.5)2014 (70)
Meropenem93 (33.3)115 (45.5)208 (40)
Tetracycline97 (77.8)1110 (90.9)2017 (85)
Sulphamethoxazole - Trimethoprim96 (66.7)1111 (100)2017 (85)
Total9977 (77.8)12198 (80.99)220175 (79.5)
  1. #T: Number of isolates tested, R%: Percentage of resistant isolates